The mechanism underlying blood pressure (BP) reduction in the high fruits and vegetables arm of the Dietary Approaches to Stop Hypertension (DASH) study is unknown but may include potassium, magnesium and fibre. This study was designed to separate minerals and fibre from other components of DASH on BP in abdominally obese individuals with metabolic syndrome with pre-hypertension to stage 1 hypertension (obese hypertensives). A total of 15 obese hypertensives and 15 lean normotensives were studied on a standardized usual diet, randomized to DASH or usual diet supplemented with potassium, magnesium and fibre to match DASH, then crossed over to the complementary diet. All diets were 3 weeks long, isocaloric and matched for sodium and calcium. In obese hypertensives, BP was lower after 3 weeks on DASH than usual diet (À7.6±1.4/ À5.3 ± 1.4 mm Hg, Po0.001/0.02) and usual diet supplemented (À6.2±1.4/À3.7±1.4 Po0.005/0.06), whereas BP was not significantly different on usual and supplemented diets. BP values were not different among the three diets in lean normotensives. Small artery elasticity was lower in obese hypertensives than in lean normotensives on the usual and supplemented diets (Po0.02). This index of endothelial function improved in obese hypertensives (Po0.02) but not lean normotensives on DASH, and was no longer different from values in lean normotensives (P40.50). DASH is more effective than potassium, magnesium and fibre supplements for lowering BP in obese hypertensives, which suggest that high fruits and vegetables DASH lowers BP and improves endothelial function in this group by nutritional factors in addition to potassium, magnesium and fibre.
Introduction
The majority of pre-hypertensive and hypertensive patients are overweight or obese. 1, 2 A substantial minority of pre-hypertensive and the majority of hypertensive patients have the metabolic syndrome. 3 Weight loss ameliorates several facets of the metabolic syndrome including elevated blood pressure (BP), 4 yet sustained weight loss is an elusive long-term endpoint for most obese people. 5 Lifestyle interventions that reduce risk without weight loss could be useful in managing metabolic syndrome-related risk and disease.
The Dietary Approaches to Stop Hypertension (DASH) eating plan, which is rich in fruits and vegetables, lowers BP and improves the lipid profile without weight loss in hypertensive individuals. 6 Although DASH lowered BP more with than without low-fat dairy products, both the diets reduced BP in hypertensive patients. Both diets are high in potassium, magnesium and fibre, which are associated with reduction of BP. [7] [8] [9] Obesity and the metabolic syndrome are linked to inflammation and oxidative stress, which contribute to endothelial dysfunction. [10] [11] [12] Endothelial dysfunction is implicated in the pathophysiology of hypertension and cardiovascular disease. 13 The fruits, vegetables and other whole foods in DASH contain numerous flavonoids and antioxidants, which may reduce oxidative stress, improve endothelial function and lower BP. 14 The high potassium, magnesium and fibre content of DASH may also improve endothelial and vascular functions. 15, 16 Our study was designed to separate the effects of minerals and fibre from other components of DASH on BP and markers of endothelial and vascular function in abdominally obese pre-hypertensive and hypertensive patients with the metabolic syndrome. Lean normotensive individuals without metabolic syndrome risk factors were studied as a healthy, time-control group. The comparators included a standardized typical Western diet, which is low in fruits, vegetables and other whole foods, the usual diet supplemented with potassium, magnesium and fibre to match DASH, and DASH fruits and vegetables without emphasis on low-fat dairy products, given its relatively poor adoption by freeliving volunteers in our earlier study. 14 The diets were isocaloric and matched for sodium and calcium.
Materials and methods

Ethics
The protocol was reviewed and approved by the Office of Research Protection and Integrity at the Medical University of South Carolina. Paid study volunteers were recruited from the staff and clinics at Medical University of South Carolina. Written informed consent was obtained from all volunteers before the screening evaluation.
Participants
Volunteers were recruited and studied from 2003 to 2006. Inclusion criteria for lean normotensives were age 21-49 years, body mass index o25 kg m À2 , waist circumference o40 inches for men and o35 inches for women, BP consistently o130/85 mm Hg on all three visits before the first study, fasting glucose o100 mg per 100 ml, fasting triglycerides o125 mg per 100 ml, high-density lipoprotein (HDL)-cholesterol X40 mg per 100 ml for men and X45 mg per 100 ml for women, total cholesterol o200 mg per 100 ml and/or total cholesterol/HDL p3.5.
Inclusion criteria for abdominally obese patients included BP 130-159/85-99 mm Hg on the three screening visits, age range of 21-49 years, waist circumference 440 inches in men and 435 inches for women, and at least one other metabolic syndrome criterion (impaired fasting glucose (100-125 mg per 100 ml), fasting triglycerides X150 mg per 100 ml or HDL-cholesterol o50 mg per 100 ml for women and o40 mg per 100 ml for men). 17 Exclusion criteria were diabetes mellitus (fasting glucose X126 mg per 100 ml or treatment), clinically evident target organ, history of stroke, transient ischaemic attack, myocardial infarction, angina pectoris or chronic heart failure.
Volunteers discontinued all non-essential prescription and non-prescription medications and supplements at least 3 weeks before beginning the study. Patients requiring medications to maintain BP o160/o100 mm Hg were excluded. Medications, which volunteers identified as essential and that were determined to have minimal effects on BP, were allowed. Examples include antihistamines for allergies, H 2 -receptor blockers and proton pump inhibitors for gastroesophageal reflux, and selective serotonin reuptake inhibitors for depression. Acetaminophen was allowed, but not non-steroidal anti-inflammatory medications.
Study diets
Participants were studied first after 3 weeks on a standardized usual diet, with an average of one fruit and one vegetable (ULFV), B1700 mg potassium, 250 mg magnesium and 11 g of fibre daily. They were randomized to DASH or ULFV-S, that is, ULFV supplemented with potassium, magnesium and fibre to match DASH. Participants completed the complementary phase of the randomized diet for 3 weeks. DASH without additional low-fat dairy was selected based on our earlier study in free-living volunteers. 14 The nutrient targets for the three diets were B50% carbohydrate, 35% fat and 15% protein with 3000 mg sodium and 700 mg calcium daily. The calcium target was within the range attained in our earlier study of the DASH combination diet in lean and obese volunteers. 14 The ULFV diet was supplemented with potassium citrate (Upsher Smith Laboratories, Maple Grove, MN, USA), or potassium chloride (Tower Laboratories Ltd, Centerbrook, CT, USA), depending on tolerability as both have similar BP effects. 5 Diets were also supplemented with magnesium oxide (Goldline Lab, Mason, OH, USA; Centerbrook, CT, USA) and (Metamucil, Procter & Gamble, Cincinnati, OH, USA) to match intake on DASH. The dietary potassium goal reflects the levels achieved with fruits and vegetables DASH. 7 The Minnesota Nutrition Data Systems (Nutrition Coordinating Center, Minneapolis, MN, USA) was used to analyze food records and pictures and estimate nutrient intake. 18 Study participants met individually with the GCRC dietician each week of the study. Sample menus of the ULFV and DASH were provided. Each participant's isocaloric energy intake was estimated using the Harris-Benedict equation. 19 Volunteers kept a food diary and received a digital camera (PenCam VR, Aiptek, Irvine, CA, USA), to photograph all food and beverages consumed for 3 days before weekly visits with the dietician. Participants collected weekly 24-h urine samples for sodium and potassium. The dietician provided advice to further enhance dietary compliance and estimated nutrient consumption and dietary compliance from 3-day food records and urine data supplemented by photographs of food and beverages consumed. 20 Calories were adjusted weekly to minimize weight changes.
Haemodynamic measurements
Blood pressure was measured with a random-zero sphygmomanometer, with the participants in sitting position, at three screening visits and weekly during the first 2 weeks of the three study diets. After 3 weeks on each diet, six supine (basal) BP readings were obtained with the random-zero device at 10-min intervals.
Small and large artery elasticity were derived using the HDI/Pulse Wave CR-2000 (Eagan, MN, USA). 21 Central (aortic) BP was determined using the Sphygmacor (SCOR-MX, West Ryde, New South Wales, Australia). 22 Aortic augmentation index was calculated. 22 Metabolic assays Plasma insulin was measured by radioimmunoassay. 23 Homoeostatic model assessment of insulin resistance index was calculated. 24 Triglycerides, total and HDL-cholesterol were measured, 25 and LDL-cholesterol was calculated. 26 Study design and protocol After 3 weeks on ULFV, participants were randomized to DASH or the ULFV-S for the next 3 weeks. Volunteers crossed over to the complementary diet for 3 additional weeks. The dietary phases were not separated by a washout.
At the end of each 3-week dietary period, participants were admitted to the outpatient GCRC at 0800 hours after an overnight fast. Intravenous access was established. Supine haemodynamic data were obtained at 10-min intervals for 60 min. Blood was then drawn for serum lipids, plasma glucose and plasma insulin.
Statistical considerations
Sample size estimates. The primary outcome variable was the last four of six supine laboratory BPs taken after 3 weeks on each diet. With 15 participants, the study had a power of greater than 90% (bo0.10) to detect the prespecified 5 mm Hg (±10 mm Hg variance) difference in systolic BP between diets within group at Pp0.05. Data analysis. Group comparisons for categorical variables, for example, gender and ethnicity, were made using w-square tests. Data for continuous variables are presented as mean±s.e. For baseline variables, such as age, nutrient intake and BP, two-sample t-tests were used to compare obese and lean groups. One-sample t-tests were used to assess changes in nutritional variables between DASH and ULFV-S in obese hypertensives. Changes in BP, nutritional and biochemical measurements across the three dietary phases within and between groups were made using linear mixed models for repeated measures. An order effect of diet order on BP was examined by Grizzle's method. Statistical analyses were performed with SAS Version 9.1. All statistical tests were two-sided, and P-values o0.05 were accepted as significant except Grizzle's method, where a P-value o0.10 indicates an order effect.
Results
Study volunteers
As shown, 102 volunteers, including 36 lean and 66 obese individuals, completed the baseline history, physical and laboratory assessment ( Figure 1 Nutritional content of the diets Fruits and vegetables on the usual and supplemented diet were lower than DASH (Table 2) . Sodium intake was comparable across the three diets, whereas potassium, magnesium and fibre were greater on ULFV-S and DASH than the baseline phase. Calcium intake was not different among the three dietary periods in lean normotensives or obese hypertensives, although mean values tended to be higher in obese hypertensives on DASH.
Nutrient differences between ULFV-S and DASH in obese hypertensives
Estimated intake of arginine, lycopene, vitamins C and alpha E, and folate were higher on DASH than ULFV-S. Soluble fibre intake was higher during ULFV-S than DASH, whereas insoluble fibre was higher on DASH than ULFV-S. Trans-fatty acid intake was lower on DASH than ULFV-S. Values for fish oils (docosohexanoic, eicosopentanoic), linolenic acid, sodium, potassium, calcium, magnesium and selenium were not different between the two diets.
BP responses to dietary intervention
Peripheral (brachial) and estimated central (aortic) systolic and diastolic pressure at the end of 3 weeks on each diet are shown for obese hypertensives and lean normotensives in Figure 2 . Systolic and diastolic pressures were lower in obese participants after 3 weeks on DASH than either ULFV or ULFV-S. BPs were not different between ULFV and ULFV-S in the obese group. Central systolic and diastolic pressures were also lower in obese participants on DASH than ULFV but were not significantly different from ULFV-S. Brachial and central systolic and diastolic BPs were not different among the three dietary periods in lean volunteers. BP differences between the dietary periods for both groups are shown in Figure 3 .
Using Grizzle's method, no carryover effect was found of diet sequence on systolic BP in lean normotensives (P ¼ 0.42), obese hypertensives (P ¼ 0.73) or all participants (P ¼ 0.89). Corresponding P-values for diastolic pressure were 0.08 (lean), 0.87 and 0.83, respectively.
Vascular function
Nutritional effects on vascular stiffness were assessed with small and large artery elasticity and aortic augmentation index. Small and large artery elasticity values in obese hypertensives were higher on DASH than the other two diets, whereas values did not change significantly in lean normotensives. The aortic augmentation index was lower (improved) in both groups on DASH than ULFV-S. In obese hypertensives, this index was also lower on ULFV-S than the usual diet (Figure 4) .
Metabolic variables
Weight, heart rate, metabolic and urine electrolyte values are shown for lean and obese volunteers during the three dietary periods ( Table 3 ). The only significant changes occurred in urine potassium and 
Abbreviations: BP, blood pressure; BMI, body mass index; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol.
DASH and BP in obese hypertensives Y Al-Solaiman et al magnesium, which were higher on DASH and ULFV-S than the usual diet (ULFV). No significant differences were observed for any of the variables in Table 3 between DASH and ULFV-S in either lean normotensives or obese hypertensives.
Discussion
Abdominally obese participants with the metabolic syndrome and (pre)hypertension had lower BP on the DASH high fruits and vegetables eating plan than a usual diet low in fruits and vegetables ((ULFV) Figures 2, 3) . BP was also lower on DASH than ULFV supplemented with potassium, magnesium and fibre (ULFV-S) to match DASH. In contrast, BP was not lower in obese hypertensives on ULFV-S than ULFV (Table 4) . Earlier work raised the possibility that the high content of potassium, magnesium and fibre in the DASH eating plan explains the beneficial BP effects. [7] [8] [9] Other studies suggest that these minerals and fibre may not fully account for the BP effects of DASH. [14] [15] [16] This study was designed to separate the effects of minerals and fibre from other components of DASH, which may include antioxidants and flavonoids, 27, 28 on BP and markers of endothelial and vascular function. The findings suggest that DASH lowers BP beyond the content of potassium, magnesium and fibre in abdominally obese (pre)-hypertensives.
Sodium can have important BP effects. 29 Although controversial, 30 calcium may have modest BP effects. 31 Sodium intake was similar across the dietary periods, although somewhat lower than a typical Western diet. The moderate sodium restriction may have limited the effects of the supplements on BP, especially potassium, which has natriuretic properties. 7 Mean calcium intake was B140 mg per day higher on DASH than on ULFV-S (P ¼ 0.07). Based on earlier studies on the BP effects of calcium, this modest difference is unlikely to explain the lower BP on DASH. 15, 16, 31 One meta-analysis found that supplemental fibre lowered BP B1.1-1.3 mm Hg and reported soluble and mixed fibre lowers BP, whereas insoluble fibre does not. 9 Soluble fibre intake was higher during ULFV-S than DASH. Thus, it is unlikely that the greater BP reduction with DASH than ULFV-S is explained by fibre composition.
Among obese hypertensives, DASH improved small artery elasticity (Figure 4) . Small artery elasticity serves as an index of endothelial function. 32, 33 The link between small artery elasticity and endothelial function is consistent with the evidence that raising fatty acids systemically 14, 33 that inhibit endothelial cell nitric oxide synthase and induce reactive oxygen species in vitro, 34, 35 impaired small artery elasticity in vivo. Our findings suggest nutritional components of DASH other than potassium, magnesium, sodium, calcium and fibre improved endothelial function in obese hypertensives.
Stiffness of the vascular system predicts adverse outcomes independently of BP. 36, 37 DASH improved small and large distensibility and reduced the aortic augmentation index, a general measure of arterial system stiffness in obese hypertensives. DASH improved the augmentation index in lean participants, despite a non-significant BP effect. These findings are consistent with the evidence that 
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Y Al-Solaiman et al DASH-like eating patterns improve cardiovascular outcomes 38 and raise the possibility that beneficial effects on arterial function may contribute. Supplements improved the aortic augmentation index in obese hypertensives, which aligns with evidence that dietary potassium, magnesium and fibre are linked to better vascular outcomes. [39] [40] [41] Extensive efforts were made to estimate intake of nutrients, which could explain the observed effects on BP and markers of endothelial and vascular function in the obese participants. Arginine, lycopene, vitamins C and E and folate intake were all higher on DASH than ULFV-S (Table 4) and may have contributed to the beneficial effects of DASH in obese volunteers with DASH. In contrast, intakes of selenium, caffeine and omega-3 fatty acids (linolenic, eicosapentanoic and docosahexanoic), which may affect BP, were not different. 26, 42 In obese participants, BP and indices of vascular function were more favourable on DASH than the control diet supplemented with potassium, magnesium and fibre to match DASH. It may be useful to examine nutritional differences between the two diets, which could explain beneficial effects of DASH. Intake of arginine, the precursor for nitric oxide, was higher in obese hypertensives on DASH than ULFV-S. Arginine improves endothelium-dependent vasodilation and small artery elasticity, 43, 44 26, 45 Lycopene intake was also greater in obese participants on DASH than ULFV-S, and may have lowered BP. 26, 46 Vitamin C intake was higher on DASH than ULFV-S. Vitamin C lowers BP 26, 47 and improves endothelial function, especially when a deficiency exists. 26 Vitamin C may lower BP by enhancing nitric oxide synthase activity. 48 Vitamin C and E supplements in rats markedly attenuated glutathione deficiencyinduced hypertension. 49 Vitamins C and E reduced arterial stiffness and improved endothelial function in hypertensives. 50 Vitamins C and E may lower BP by scavenging reactive oxygen species, downregulating NADPH oxidase and increasing nitric oxide synthase. 50, 51 Yet, vitamin C and grape-seed polyphenols together 46 or a-tocopherol alone can raise BP. 52 Estimated folate consumption was greater on DASH than ULFV-S. Studies suggest folate lowers BP, 53, 54 reduces hypertension incidence 55 and improves endothelial function. 56, 57 Several studies cited above indicate specific components of DASH, other than potassium, magnesium and fibre, lower BP and improve endothelial function. DASH could also reduce consumption of factors, such as refined sugar, which may raise BP.
Limitations
Volunteers prepared their own meals, which may have compromised adherence in contrast to DASH, in which volunteers received food and beverages from a metabolic kitchen. The weekly 3-day food records, photographs and timed urine collections suggested good adherence. Moreover, our data in free-living volunteers may be more applicable to patients in community-based clinical settings than metabolic feeding studies.
The dietary interventions were 3 weeks long and not separated by washout periods. The DASH report and our studies 6, 14 indicated that most of the BP effect occurred within 2-3 weeks. An order effect was not observed in our earlier or current study. 14 The dietary interventions were unblinded. Thus, patient and investigator expectations may have influenced the results. To minimize investigator bias, a random-zero sphygmomanometer was used to measure BP, the primary outcome variable. The limited effect of the supplemented diet on BP may be partially due to the comparatively low sodium intake of B3000 mg daily. In our earlier work, despite numerous prompts from the study dietician, free-living volunteers continued to consume significantly less than one low-fat dairy product daily. Thus, this study examined only the high fruits and vegetables DASH, and we cannot extrapolate our results to the combination diet.
We studied lean normotensives without and obese pre-hypertensives and hypertensives with the metabolic syndrome, and cannot extrapolate beyond the groups studied. However, we believe the study findings are important, as obese, metabolic syndrome individuals comprise a large proportion of all patients with pre-hypertension and hypertension. Compared with the control diet, BP effects of high fruits and vegetables DASH in our study are comparable with the original report. 6 Specifically, BP changes in this study and DASH fruits and vegetables were À2.0/À1.3 (lean normtensives (current)) vs À0.8/À0.3 (non-hypertensives (DASH)) and À7.6/À5.3 (obese hypertensives (current)) vs À7.2/ À2.8 (hypertensives (DASH)). We cannot exclude the possibility that the potassium, magnesium and fibre contents of food in the high fruits and vegetables eating plan lower BP by interacting with other nutrients in the high fruits and vegetables eating plan. 14 Our study shows that the DASH fruits and vegetables eating plan lowers BP in obese, prehypertensive and hypertensive patients with the metabolic syndrome. Moreover, DASH improved their endothelial function and reduced vascular stiffness. The beneficial effects were less evident in obese participants when a usual diet was supplemented with potassium, magnesium and fibre to match DASH. The data suggest that DASH lowers BP and improves endothelial function in obese, metabolic syndrome individuals with elevated BP beyond potassium, magnesium and fibre.
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